Improving access to RSV immunization for high-risk infants
RSV I-PREP: Improving Evidence-Based Implementation of RSV Immuno-Prophylaxis Within Ethical and Policy Contexts
This study is looking at how to make sure that high-risk infants, especially those with heart conditions, get the important RSV vaccine they need, by figuring out what makes it easier or harder for them to receive it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lurie Children's Hospital of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11079564 on NIH RePORTER |
What this research studies
This research focuses on enhancing the delivery of immunoprophylaxis against respiratory syncytial virus (RSV) for infants at high risk, particularly those with congenital heart disease. The project aims to identify barriers and facilitators affecting the administration of this critical treatment, which is currently underutilized despite its importance. By evaluating healthcare policies and access issues, the research seeks to improve the overall implementation of RSV immunization for vulnerable children. The approach includes assessing factors at the patient, provider, and institutional levels to better understand why many eligible infants do not receive their complete immunization.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants under two years old, particularly those with congenital heart disease or other special healthcare needs.
Not a fit: Patients who are not infants or do not have high-risk conditions related to RSV, such as congenital heart disease, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of high-risk infants receiving essential RSV immunization, reducing morbidity and mortality associated with the virus.
How similar studies have performed: Previous research has shown success in improving immunization rates through targeted policy changes and implementation strategies, indicating that this approach has potential.
Where this research is happening
Chicago, United States
- Lurie Children's Hospital of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Saper, Jennifer Kusma — Lurie Children's Hospital of Chicago
- Study coordinator: Saper, Jennifer Kusma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.